vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $20.6M, roughly 1.5× Entrada Therapeutics, Inc.). FGI Industries Ltd. runs the higher net margin — -8.6% vs -84.4%, a 75.8% gap on every dollar of revenue. On growth, FGI Industries Ltd. posted the faster year-over-year revenue change (-14.4% vs -65.2%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $-39.7M). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -0.5%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
FGI vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.5M | $20.6M |
| Net Profit | $-2.6M | $-17.3M |
| Gross Margin | 26.7% | — |
| Operating Margin | -2.2% | -106.0% |
| Net Margin | -8.6% | -84.4% |
| Revenue YoY | -14.4% | -65.2% |
| Net Profit YoY | -553.1% | -173.8% |
| EPS (diluted) | $-1.63 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.5M | — | ||
| Q3 25 | $35.8M | — | ||
| Q2 25 | $31.0M | — | ||
| Q1 25 | $33.2M | $20.6M | ||
| Q4 24 | $35.6M | $37.4M | ||
| Q3 24 | $36.1M | $19.6M | ||
| Q2 24 | $29.4M | $94.7M | ||
| Q1 24 | $30.8M | $59.1M |
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-1.7M | — | ||
| Q2 25 | $-1.2M | — | ||
| Q1 25 | $-629.1K | $-17.3M | ||
| Q4 24 | $-402.3K | $1.1M | ||
| Q3 24 | $-550.1K | $-14.0M | ||
| Q2 24 | $163.6K | $55.0M | ||
| Q1 24 | $-412.2K | $23.5M |
| Q4 25 | 26.7% | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 26.8% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 30.5% | — | ||
| Q1 24 | 27.4% | — |
| Q4 25 | -2.2% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | -2.7% | — | ||
| Q1 25 | -3.9% | -106.0% | ||
| Q4 24 | -3.5% | -15.7% | ||
| Q3 24 | -0.2% | -110.7% | ||
| Q2 24 | -1.5% | 56.4% | ||
| Q1 24 | -1.0% | 35.7% |
| Q4 25 | -8.6% | — | ||
| Q3 25 | -4.6% | — | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | -1.9% | -84.4% | ||
| Q4 24 | -1.1% | 3.0% | ||
| Q3 24 | -1.5% | -71.7% | ||
| Q2 24 | 0.6% | 58.1% | ||
| Q1 24 | -1.3% | 39.7% |
| Q4 25 | $-1.63 | — | ||
| Q3 25 | $-0.86 | — | ||
| Q2 25 | $-0.64 | — | ||
| Q1 25 | $-0.07 | $-0.42 | ||
| Q4 24 | $-0.38 | $-0.20 | ||
| Q3 24 | $-0.29 | $-0.35 | ||
| Q2 24 | $0.08 | $1.55 | ||
| Q1 24 | $-0.04 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $17.3M | $417.3M |
| Total Assets | $69.5M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | — | ||
| Q3 25 | $1.9M | — | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $1.2M | $67.8M | ||
| Q4 24 | $4.6M | $101.2M | ||
| Q3 24 | $3.0M | $78.0M | ||
| Q2 24 | $1.3M | $185.3M | ||
| Q1 24 | $3.3M | $68.4M |
| Q4 25 | $17.3M | — | ||
| Q3 25 | $19.7M | — | ||
| Q2 25 | $21.3M | — | ||
| Q1 25 | $21.8M | $417.3M | ||
| Q4 24 | $22.3M | $428.7M | ||
| Q3 24 | $23.5M | $422.4M | ||
| Q2 24 | $23.8M | $429.9M | ||
| Q1 24 | $23.9M | $269.4M |
| Q4 25 | $69.5M | — | ||
| Q3 25 | $73.0M | — | ||
| Q2 25 | $71.7M | — | ||
| Q1 25 | $68.5M | $486.5M | ||
| Q4 24 | $75.5M | $526.3M | ||
| Q3 24 | $74.7M | $554.6M | ||
| Q2 24 | $69.9M | $582.0M | ||
| Q1 24 | $68.6M | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-38.5M |
| Free Cash FlowOCF − Capex | $2.3M | $-39.7M |
| FCF MarginFCF / Revenue | 7.5% | -192.9% |
| Capex IntensityCapex / Revenue | 0.2% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | — | ||
| Q3 25 | $-1.9M | — | ||
| Q2 25 | $7.6M | — | ||
| Q1 25 | $-7.4M | $-38.5M | ||
| Q4 24 | $617.4K | $-31.6M | ||
| Q3 24 | $-915.0K | $-24.3M | ||
| Q2 24 | $862.1K | $39.8M | ||
| Q1 24 | $-8.0M | $-25.5M |
| Q4 25 | $2.3M | — | ||
| Q3 25 | $-2.1M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $-7.7M | $-39.7M | ||
| Q4 24 | $-214.1K | $-32.2M | ||
| Q3 24 | $-1.1M | $-24.9M | ||
| Q2 24 | $281.5K | $38.8M | ||
| Q1 24 | $-8.6M | $-26.4M |
| Q4 25 | 7.5% | — | ||
| Q3 25 | -5.9% | — | ||
| Q2 25 | 23.8% | — | ||
| Q1 25 | -23.3% | -192.9% | ||
| Q4 24 | -0.6% | -86.2% | ||
| Q3 24 | -3.0% | -127.3% | ||
| Q2 24 | 1.0% | 41.0% | ||
| Q1 24 | -28.0% | -44.6% |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 1.1% | 5.6% | ||
| Q4 24 | 2.3% | 1.7% | ||
| Q3 24 | 0.5% | 3.3% | ||
| Q2 24 | 2.0% | 1.1% | ||
| Q1 24 | 2.0% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.27× | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
TRDA
Segment breakdown not available.
